Not sure of the time scale when this device will be available, but the following looks promising and is non-invasive:
http://www.gluco-wise.com/
Funnily enough, I contacted gluco-wise a couple of times over the past year and they just seem like another outfit with no substance.
Yes they have a flashy website with all the right pictures, but they haven't updated their website for over a year, they don't answer emails, and their facebook page is like a tumbleweed after the initial bravado from 2014/2015.
If they are legit, then they need a marketing person to keep us informed, otherwise it's just another flash in the pan.
Appreciate the feedback.
I've written to pretty much every company associated with all these potentially Non-invasive monitoring devices:
Glucotrack, Glucowise, SugarBeat to name a few.
None of them are interested in answering emails or providing information. Surely some of them should have a marketing team if they were genuine...
A couple of them say on their websites about devices being ready being authorized for Europe, but when you contact them, zilch.
Oh well, don't believe the hype.
Not surprised too much by this. the CG-EGA (Clarke Error Grid) displays not just point accuracy, but also rate accuracy, In other words a CGM has to track moving values. In the test the sample rate was increased to 12 spm from 3 spm, and is probably showing the meter is running faster than it can cope with accuracy. What the results reported show is that 75% of samples were within 20% of reference, 98% were within reasonable but safe limits, and only 2% of samples could lead to an unsafe report.A recent press release from Nemaura suggests they aren't getting the accuracy they might like in their clinical trials that already underway:
"The sugarBEATskin-patch is designed to display real time glucose readings on a reader via blue tooth, or allow retrospective data evaluation on a reader or mobile phone App. Nemaura today issued results of an interim study of eight patient day visits, consisting of five Type I diabetics, two of whom made two visits each, and one Type II insulin dependent diabetic patient, with up to 12 hours device wear time per day. Previously Nemaura reported data on over 100 patient days clinical evaluation of the sugarBEATsystem with glucose levels measured once every 20 minutes, thus three times an hour. This study was designed to establish the possibility of measuring glucose levels at five minute intervals, 12 times every hour. The evaluation consisted of 81 paired data points, with a single finger prick calibration, and glucose range between 70-400 mg/dl. The results indicated a MARD of 14.05%, and 75% of the data in Zone A, and over 98% of the data in Zones A and B of the Clarke Error grid. There were no reports of skin irritation or other adverse events.
Nemaura Medical anticipate launching sugarBEATin Europe at the end of 2016, and stated that this result provides further confidence in sugarBEAT, and positions it well amongst current CGM’s."
Freestyle libre there are quite a few threads on it ...MENTERING Continously.
I saw a programme BBC Truth about Carbs a brilliant programme but - they were using a monitor stuck on their arms and picked up on phone app.
Anyone tell me what it was, where, how much ?....?
Anyone tell me what it was, where, how much ?....?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?